Envveno Medical Corp (NVNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,943 | 4,465 | 2,753 | 2,741 | 4,189 |
| Receivables | N/A | N/A | 27 | 32 | 28 |
| Inventories | 117 | N/A | N/A | N/A | N/A |
| TOTAL | $3,060 | $4,630 | $2,946 | $2,837 | $4,364 |
| Non-Current Assets | |||||
| PPE Net | 350 | 194 | 25 | 26 | 25 |
| Intangibles | 608 | 628 | 647 | 667 | 1,017 |
| Other Non-Current Assets | 1,733 | 1,802 | 1,870 | 30 | 30 |
| TOTAL | $2,691 | $2,623 | $2,542 | $723 | $1,072 |
| Total Assets | $5,751 | $7,253 | $5,488 | $3,559 | $5,436 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,211 | 1,197 | 1,096 | 1,077 | 1,223 |
| Accrued Expenses | 500 | 382 | 439 | 413 | 635 |
| TOTAL | $2,016 | $1,883 | $1,839 | $1,523 | $1,862 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 33 | 33 | 33 | 33 | N/A |
| Other Non-Current Liabilities | 652 | 718 | 785 | 0 | 0 |
| TOTAL | $652 | $718 | $785 | $N/A | $35 |
| Total Liabilities | $2,667 | $2,601 | $2,623 | $1,523 | $1,893 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20 | 20 | 16 | 16 | 13 |
| Retained earnings | -53,897 | -52,082 | -50,136 | -48,563 | -46,781 |
| TOTAL | $3,084 | $4,652 | $2,865 | $2,036 | $3,542 |
| Total Liabilities And Equity | $5,751 | $7,253 | $5,488 | $3,559 | $5,436 |